SCHEMBL2398930

SCHEMBL2398930

O=CC(Cl)(Cl)COCc1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.50
KDM4E B2RXH2 1/20 0.47
POLB P06746 1/20 0.47
ALDH1A1 P00352 4/20 0.40
CA1 P00915 4/20 0.39
IDO1 P14902 1/20 0.38
CCNB2 O95067 1/20 0.37
CDK1 P06493 1/20 0.37
CDK4 P11802 1/20 0.37
CCNB1 P14635 1/20 0.37
CCND1 P24385 1/20 0.37
CCNB3 Q8WWL7 1/20 0.37
MAOA P21397 1/20 0.37
MAOB P27338 1/20 0.37
AGXT P21549 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
CA2 P00918 3/20 0.36
CA9 Q16790 3/20 0.36
CA7 P43166 2/20 0.36
NPC1 O15118 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8570929 0.78 TSHR (0.61) TSHRKDM4EPOLBALDH1A1CA1
SCHEMBL8743531 0.78 TSHR (0.50) TSHRKDM4EPOLBALDH1A1CA1
SCHEMBL4889465 0.78 TSHR (0.50) TSHRKDM4EPOLBALDH1A1CA1
SCHEMBL18526730 0.75 KDM4E (0.53) TSHRKDM4EPOLBALDH1A1CA1
SCHEMBL9521927 0.75 TSHR (0.47) TSHRKDM4EPOLBALDH1A1CA1
SCHEMBL2398268 0.74 SMN1; SMN2 (0.42) ALDH1A1MAOBSMN1; SMN2
SCHEMBL9521935 0.74 TSHR (0.45) TSHRKDM4EPOLBALDH1A1CA1
SCHEMBL11146323 0.73 TSHR (0.67) TSHRKDM4EPOLBALDH1A1CA1
SCHEMBL13888734 0.73 KDM4E (0.46) TSHRKDM4EPOLBALDH1A1CA1
SCHEMBL20267477 0.71 TSHR (0.47) TSHRKDM4EPOLBALDH1A1CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130274470-A1 Triazolium Carbene Catalysts and Stereoselective Bond Forming Reactions Thereof NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2013-10-17 US disclosed
US-20110224431-A1 Triazolium Carbene Catalysts and Stereoselective Bond Forming Reactions Thereof COLORADO STATE UNIVERSITY RESEARCH FOUNDATION (US) 2011-09-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130274470-A1 Triazolium Carbene Catalysts and Stereoselective Bond Forming Reactions Thereof HDHD5, DCX, CLK2 TSHR 1020/4885KDM4E 4494/4885POLB 996/4885
US-20110224431-A1 Triazolium Carbene Catalysts and Stereoselective Bond Forming Reactions Thereof HDHD5, DCX, CLK2 TSHR 1020/4885KDM4E 4494/4885POLB 996/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.